Show simple item record

dc.contributor.authorKramer, RD
dc.contributor.authorRogers, MAM
dc.contributor.authorConte, M
dc.contributor.authorMann, J
dc.contributor.authorSaint, S
dc.contributor.authorChopra, V
dc.date.accessioned2020-03-09T06:40:04Z
dc.date.available2020-03-09T06:40:04Z
dc.date.issued2017
dc.identifier.issn0196-6553
dc.identifier.doi10.1016/j.ajic.2016.07.021
dc.identifier.urihttp://hdl.handle.net/10072/392218
dc.description.abstractBackground Antimicrobial peripherally inserted central catheters (PICCs) may reduce the risk of central line-associated bloodstream infection (CLABSI). However, data regarding efficacy are limited. We aimed to evaluate whether antimicrobial PICCs are associated with CLABSI reduction. Methods MEDLINE, EMBASE, CINHAL, and Web of Science were searched from inception to July 2016; conference proceedings were searched to identify additional studies. Study selection and data extraction were performed independently by 2 authors. Results Of 597 citations identified, 8 studies involving 12,879 patients met eligibility criteria. Studies included adult and pediatric patients from intensive care, long-term care, and general ward settings. The incidence of CLABSI in patients with antimicrobial PICCs was 0.2% (95% confidence interval [CI], 0.0%-0.5%), and the incidence among nonantimicrobial catheters was 5.3% (95% CI, 2.6%-8.8%). Compared with noncoated PICCs, antimicrobial PICCs were associated with a significant reduction in CLABSI (relative risk [RR], 0.29; 95% CI, 0.10-0.78). Statistical heterogeneity (I2, 71.6%; T2 = 1.07) was resolved by publication type, with peer-reviewed articles showing greater reduction in CLABSI (RR, 0.21; 95% CI, 0.06-0.74). Twenty-six patients (95% CI, 21-75) need to be treated with antimicrobial PICCs to prevent 1 CLABSI. Studies of adults at greater baseline risk of CLABSI experienced greater reduction in CLABSI (RR, 0.20; P = .003). Conclusions Available evidence suggests that antimicrobial PICCs may reduce CLABSI, especially in high-risk subgroups. Randomized trials are needed to assess efficacy across patient populations.
dc.description.peerreviewedYes
dc.languageeng
dc.publisherElsevier BV
dc.relation.ispartofpagefrom108
dc.relation.ispartofpageto114
dc.relation.ispartofissue2
dc.relation.ispartofjournalAmerican Journal of Infection Control
dc.relation.ispartofvolume45
dc.subject.fieldofresearchNursing
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchcode1110
dc.subject.fieldofresearchcode1117
dc.subject.keywordsAntimicrobial-coated
dc.subject.keywordsCentral venous access
dc.subject.keywordsInfection prevention
dc.titleAre antimicrobial peripherally inserted central catheters associated with reduction in central line–associated bloodstream infection? A systematic review and meta-analysis
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationKramer, RD; Rogers, MAM; Conte, M; Mann, J; Saint, S; Chopra, V, Are antimicrobial peripherally inserted central catheters associated with reduction in central line–associated bloodstream infection? A systematic review and meta-analysis, American Journal of Infection Control, 2017, 45 (2), pp. 108-114
dcterms.dateAccepted2016-07-15
dc.date.updated2020-03-09T06:39:22Z
gro.hasfulltextNo Full Text
gro.griffith.authorChopra, Vineet


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record